Radio-Interview anlässlich des Welt-Rheumatages

Oskar Psenak Weltrheumatag; 12.10.2021; Salzburg. 2021.

Radio-Interview anlässlich des Welt-Rheumatages

Oskar Psenak Weltrheumatag; 12.10.2021; Radio Salzburg. 2021.

Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.

Kiem, D; Leisch, M; Neureiter, D; Haslauer, T; Egle, A; Melchardt, T; Topp, MS; Greil, R; Int J Mol Sci. 2021; 22(11):

Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.

Binder, HM; Maeding, N; Wolf, M; Cronemberger Andrade, A; Vari, B; Krisch, L; Gomes, FG; Blöchl, C; Muigg, K; Poupardin, R; Raninger, AM; Heuser, T; Obermayer, A; Ebner-Peking, P; Pleyer, L; Greil, R; Huber, CG; Schallmoser, K; Strunk, D; Cells. 2021; 10(12):

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Borchmann, P; Plutschow, A; Kobe, C; Greil, R; Meissner, J; Topp, MS; Ostermann, H; Dierlamm, J; Mohm, J; Thiemer, J; Sokler, M; Kerkhoff, A; Ahlborn, M; Halbsguth, TV; Martin, S; Keller, U; Balabanov, S; Pabst, T; Vogelhuber, M; Huttmann, A; Wilhelm, M; Zijlstra, JM; Moccia, A; Kuhnert, G; Brockelmann, PJ; von Tresckow, B; Fuchs, M; Klimm, B; Rosenwald, A; Eich, H; Baues, C; Marnitz, S; Hallek, M; Diehl, V; Dietlein, M; Engert, A LANCET ONCOL. 2021; 22(2): 223-234.

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.

Morschhauser, F; Feugier, P; Flinn, IW; Gasiorowski, R; Greil, R; Illes, A; Johnson, NA; Larouche, JF; Lugtenburg, PJ; Patti, C; Salles, GA; Trneny, M; de Vos, S; Mir, F; Samineni, D; Kim, SY; Jiang, YW; Punnoose, E; Sinha, A; Clark, E; Spielewoy, N; Humphrey, K; Bazeos, A; Zelenetz, AD BLOOD. 2021; 137(5): 600-609.

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.

Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Schlick, K; Zaborsky, N; Steiner, M; Greil, R; Egle, A; Melchardt, T; Cancers (Basel). 2021; 13(4):

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.

Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wagner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P; Support Care Cancer. 2021; 29(9): 519-5207.

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors.

Huemer, F; Leisch, M; Geisberger, R; Zaborsky, N; Greil, R; Pharmaceuticals (Basel). 2021; 14(2):

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA).

Hecht, JR; Lonardi, S; Bendell, J; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Wang, H; Hozak, RR; Gueorguieva, I; Lin, Y; Rao, S; Ryoo, BY J CLIN ONCOL. 2021; 39(10): 1108-1118.